Stock Ratings / Consumer Discretionary / NCI / insiders

PASW (34) TLF (43) FMFC (62) BIRD (37) ⌘ Pro Terminal →

Neo-Concept International Group Holdings Limited (Class A) (NCI) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

Q: Are NCI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies NCI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

$0.73 -1.68% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.73

Neo-Concept International Group Holdings Limited (Class A) (NCI) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • SELL / AVOID Cap $6.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.73 (-0.49%)🧬 Disciplined Float (+0.72% YoY Shares)⚙️ Cash Engine: 10/20 (D) • 12.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D · Rk D-

Each axis scored 0–20

12M PRICE TARGET CONE-6.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for NCI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (42/100 Composite)

🔍 WHY NCI SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+12/20 pts (29% of score)

20D Institutional Volume Accumulation (±12.5% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+10/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 12.7% FCF Margin ($2.2M FCF) & 36.9% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution5/20 pts (-15 pt drag)

Disciplined Float (+0.72% YoY Shares) & executive Form 4 sales trim 15 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$0.88-30.7% Next Q

Q2 (-2Q)

Grade D$0.61+29.5% Next Q

Q3 (-1Q)

Grade D$0.79-7.6% Next Q

Current

Grade D-$0.73-7% Hist 90D α

Trajectory: C- (50) → D- (42)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a NCI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While NCI currently carries a cautious 42/100 (D-) rating due to Insider Conviction & Share Dilution (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($7.13) and Max Pain ($0.77) forces dealer call-delta covering toward $116.00.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $NCI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “NCI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 42%NO 58%Trade / Inspect Odds →

SEC FORM 4 × 13F HEDGE FUNDS × CONGRESSIONAL STOCK ACT

NCI Smart-Money Thermometer: NET EXECUTIVE TRIMMING / PROFIT-TAKING

Explore All 13F & Congress Whales →

▲ Disclosed Buys: 0 ($0)▼ Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (NCI)

No recent open-market Form 4 cluster sales or emergency dumps flagged on NCI. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring NCI)

✓Walkthrough of NCI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

NCI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -91.30%🛡️ HOLDING TREND SUPPORT

2026-10-30O $0.70H $0.73L $0.65C $0.73VOL 83.5K

RES: $18.56SUP: $0.01SMA50: $7.13SMA200: $15.91

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

NCI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 NCI Butterfly Map → + Track NCI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

48.0%/yr Implied 5Y Growth

vs. -41.9% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on NCI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for NCI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for NCI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (NCI)

Consumer Discretionary Rank #800 of 1011 ⚔️ PASW vs NCI Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (NCI vs. PASW, TLF, FMFC, BIRD)

Industry: Apparel (27 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Neo-Concept International Group Holdings Limited (Class A) (NCI) ranks #800 by composite RQD confidence (42/100, grade D-) and #952 by equity capitalization ($6.6M). Within this direct 5-issuer industry benchmark cohort, NCI leads on earnings valuation at 153.8x trailing P/E, while NCI leads on capital efficiency and profitability with 2.6% ROIC and 36.9% gross margin. FMFC currently holds the highest overall quantitative score in the immediate peer group at 62/100 (C) compared with NCI at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
NCI ACTIVE Neo-Concept International Group Holdings Limited (Class A)	D-	42/100	153.8x	36.9%	2.6%	-1.68%	$6.6M	Benchmark Subject
PASW Ping An Biomedical Co. Ltd. (Class A)	E	34/100	—	2.8%	—	-0.20%	$15.6M	/pasw-vs-nci →
TLF Tandy Leather Factory Inc.	D-	43/100	—	57.0%	-2.1%	+0.44%	$18.5M	/tlf-vs-nci →
FMFC Kandal M Venture Limited (Class A)	C	62/100	—	—	—	+3.83%	$1.9M	/fmfc-vs-nci →
BIRD Smartbird Inc. (Class A)	D-	37/100	—	41.0%	-35.0%	-0.93%	$25.0M	/bird-vs-nci →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001916331

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Neo-Concept International Group Holdings Limited (Class A) (NCI) reported GAAP revenue of $17.6M (-41.9% vs. FY2024 revenue of $30.3M , and -20.9% cumulative change since FY2023) , GAAP net income of $42.6K, operating cash flow of $2.7M, and free cash flow of $2.2M (+566.5% YoY). On the balance sheet, NCI closed FY2025 with $14.9M in total assets against $0 in total debt (Altman Z-Score: 1.49, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$17.6M	$42.6K	$2.7M	$2.2M	$14.9M	—
FY2024 (FY)	2024-12-31	$30.3M	$1.0M	$55.1K	-$478.4K	$17.5M	—
FY2023 (FY)	2023-12-31	$22.3M	$565.2K	-$6.3M	-$6.3M	—	—

3. NCI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is NCI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Neo-Concept International Group Holdings Limited (Class A) (NASDAQ: NCI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $0.73 (-1.68% 1D, market cap $6.6M). Pillar breakdown: Fundamental Cash Engine 10/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 7/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1011 tracked Consumer Discretionary issuers, NCI ranks #800 in composite RQD confidence.

How does NCI compare to PASW and TLF in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Apparel), NCI carries a Roarable D- (42/100 RQD), trailing P/E of 153.8x, gross margin of 36.9%, and ROIC of 2.6%. By comparison, PASW (Ping An Biomedical Co. Ltd. (Class A)) holds a E grade (34/100 RQD, P/E N/A, ROIC —, cap $15.6M) and TLF (Tandy Leather Factory Inc.) posts a D- grade (43/100 RQD, P/E N/A, ROIC -2.1%, cap $18.5M). Among the 5-stock peer group, NCI leads on earnings multiple (153.8x) while NCI leads on capital efficiency (2.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for NCI?

Per NCI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001916331), Neo-Concept International Group Holdings Limited (Class A) generated $17.6M in revenue (-41.9% YoY), $42.6K in net income, and $2.2M in free cash flow against $14.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is NCI trading relative to its 50-day, 200-day, and 52-week technical levels?

NCI last traded at $0.73 (-1.68% on volume of 71,647 shares), positioning the stock -89.76% below its 50-day simple moving average ($7.13) and -95.41% below its 200-day simple moving average ($15.91). Across its 52-week range of $0.57 to $110.48, NCI sits at the 0.1% percentile with a 14-day RSI of 17.7 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.00 to $0.82).

NCI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Are NCI insiders and hedge funds buying or selling?

Roarable's SEC Form 4 and 13F Whale Thermometer currently classifies NCI leadership and institutional positioning as: NET EXECUTIVE TRIMMING / PROFIT-TAKING.

Direct Sub-Reports: NCI RQD Cockpit NCI 12M Forecast NCI Earnings & Move NCI Dividends & DRIP NCI Insiders & 13F NCI Whale Options NCI Profit Sankey NCI News & Why